FR2925332B1 - Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines - Google Patents

Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines

Info

Publication number
FR2925332B1
FR2925332B1 FR0800858A FR0800858A FR2925332B1 FR 2925332 B1 FR2925332 B1 FR 2925332B1 FR 0800858 A FR0800858 A FR 0800858A FR 0800858 A FR0800858 A FR 0800858A FR 2925332 B1 FR2925332 B1 FR 2925332B1
Authority
FR
France
Prior art keywords
spotlight
hydrolyzate
active ingredient
aquaporin synthesis
activator active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0800858A
Other languages
English (en)
Other versions
FR2925332A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0800858A priority Critical patent/FR2925332B1/fr
Publication of FR2925332A1 publication Critical patent/FR2925332A1/fr
Application granted granted Critical
Publication of FR2925332B1 publication Critical patent/FR2925332B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
FR0800858A 2007-12-21 2008-02-18 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines Expired - Fee Related FR2925332B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0800858A FR2925332B1 (fr) 2007-12-21 2008-02-18 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0708980A FR2925327A1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR0800858A FR2925332B1 (fr) 2007-12-21 2008-02-18 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines

Publications (2)

Publication Number Publication Date
FR2925332A1 FR2925332A1 (fr) 2009-06-26
FR2925332B1 true FR2925332B1 (fr) 2010-05-14

Family

ID=39832675

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0708980A Pending FR2925327A1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR0800858A Expired - Fee Related FR2925332B1 (fr) 2007-12-21 2008-02-18 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0708980A Pending FR2925327A1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines

Country Status (1)

Country Link
FR (2) FR2925327A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940125B1 (fr) 2008-12-23 2013-03-22 Isp Investments Inc Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
FR2940291B1 (fr) 2008-12-23 2012-12-21 Isp Investments Inc Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944527B1 (fr) * 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
FR2944446B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2944526B1 (fr) 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
FR2944445B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2971711B1 (fr) * 2011-02-18 2014-06-13 Isp Investments Inc Composition cosmetique comprenant un extrait de petit epeautre en tant qu'agent activateur de la synthese des proteines de la matrice extracellulaire
ES2396815B1 (es) 2011-05-23 2014-01-20 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana plasmática extraídas de plantas enriquecidas en proteínas transportadoras de membrana.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873918B1 (fr) * 2004-08-06 2006-11-24 Vincience Sa Utilisation d'un extrait de triticum monococcum comme principe actif dans une composition cosmetique et/ou pharmaceutique
FR2889949B1 (fr) * 2005-08-26 2014-01-10 Jean Noel Thorel Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus

Also Published As

Publication number Publication date
FR2925332A1 (fr) 2009-06-26
FR2925327A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
FR2925332B1 (fr) Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR2925326B1 (fr) Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines
FR2925325B1 (fr) Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines
CR10662A (es) Compuestos de metilpiridopirimidinona
FR2925329B1 (fr) Utilisation d'un hydrolysat d'avoine en tant que principe actif activateur de la synthese des aquaporines
SV2010003472A (es) Compuestos de pirazol
DE602007010269D1 (de) Synthese von acylaminoalkenylenamiden als substanz-p-antagonisten
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
BRPI0813992A2 (pt) composto 951: um ácido bifeniloxipropanoico como modulador de crth2 e intermediários
HN2008001191A (es) Compuestos de biciclolactama sustituida
MA32797B1 (fr) Formes cristallines de la (r)-5[3-chloro-4-(2,3-dihydroxy-propoxy)-benz-[z]-ylidène]-2-([z]-propylimino)-3-o-tolyl- thiazolidin-4-one
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
FR2925330B1 (fr) Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines
MA28535B1 (fr) Utilisation de composes organiques
NI200900155A (es) COMPUESTOS DE 2-AMINO PIRIMIDINA. Caso: PC 33441A
CR10479A (es) Modulares bencimidazolicos de vr1
CR8572A (es) Derivados de oxidiazolona como agonistas de la actividad de delta ppar
GT200800251A (es) Nitrilos espirociclicos como inhibidores de proteasa
SV2004001756A (es) Nueva difenilazetidinona con propiedades fisiologicas mejoraradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso
FR2916633B1 (fr) Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1
BRPI0916069A2 (pt) "composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição"
FR2925331B1 (fr) Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines
EA201100286A1 (ru) Композиция кветиапина
AR060189A1 (es) Sales de malato y polimorfos de acido (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico
ATE390411T1 (de) Stereoselektive synthese von vitamin-d-analoga

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20191006